SUBSCRIBE
SUBSCRIBE
News   Business

Orbus Pharma Inc. Reports Third Quarter 2006 Results

November 6, 2006 | 
1 min read
TORONTO, ONTARIO--(CCNMatthews - Nov. 6, 2006) - Orbus Pharma Inc. (TSX:ORB) reported that the net loss for the first nine months of 2006 was $4,500 ($0.12 per share) compared to $5,091 ($0.17 per share) in 2005.
Earnings
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Pfizer, Geron Downsize To Streamline Costs
December 12, 2025
 · 
95 min read
 · 
BioSpace Editorial Staff
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Pfizer's signage outside its office in Canada/iStock, JHVEPhoto
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
December 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration
Mergers & acquisitions
Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend
December 10, 2025
 · 
1 min read
 · 
Annalee Armstrong